Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2856
Title: | Epidemiology and long-term neurological sequelae of childhood herpes simplex CNS infection | Authors: | Clark, J. E. Kapoor, V. Heney, C. Jones, C. A. Nourse, C. Lai, M. M. Vaska, V. L. Britton, P. N. Berkhout, A. |
Issue Date: | 2022 | Source: | , 2022 | Journal: | Journal of Paediatrics and Child Health | Abstract: | Aim: Herpes simplex CNS infection is a rare but important cause of neurological disability. Long term outcomes after HSV CNS infection in Australia have not yet been fully described. We sought to provide a comprehensive review of HSV CNS infection in children using a retrospective 13-year evaluation of statewide laboratory and clinical records and a parent survey conducted at least one year after the initial infection. Methods: All positive PCR HSV 1 and 2 results from cerebrospinal fluid (CSF) or brain tissue were obtained from Queensland pathology providers for children aged 0–16 years between 1 January 2005 and 31 December 2017. Clinical data were obtained from patient records and longer-term outcomes via parent survey at least 1 year after initial infection. Results: Forty-three children were identified over the 13-year period, 17 (39.5%) neonates and 26 (60.4%) non-neonates. The annual incidence for HSV CNS infection in Queensland children aged ≤16 years was 0.3/100 000 (95% confidence intervals (CIs): 0.2–0.4) with neonates at highest risk (incidence 2.5/100 000 live births, 95% CI: 1.5–3.9). HSV 1 was the predominant serotype in both neonates and non-neonates (9/17, 52.9% neonates and 19/26, 73.1% non-neonates). Seven (16.3%) children died, five (5/17, 29.4% neonates), directly attributable to HSV CNS infection (all neonates). Twenty-five (58.1%) had neurological morbidity at discharge (9/17 neonates (52.9%) vs. 16/26 (61.5%) non-neonates) and 20/27 (74.1%) reported long-term neurological morbidity at follow-up (5/9 neonates (55.6%) vs. 15/18 non-neonates (83.3%)). Seven children (two neonates and four non-neonates) with long-term neurological sequelae had no neurological morbidity identified at discharge. Conclusion: Significant long-term neurologic sequelae were seen in children with HSV CNS infection even in children with no neurological disability identified at discharge from hospital. Careful neurodevelopmental follow-up of all children is recommended.L20163889022022-05-10 | DOI: | 10.1111/jpc.15992 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2016388902&from=exporthttp://dx.doi.org/10.1111/jpc.15992 | | Keywords: | central nervous system infection;cerebrospinal fluid;child;childhood;clinical article;complication;encephalitis;female;follow up;herpes simplex;Herpes simplex virus;human;Human alphaherpesvirus 1;incidence;brain tissue;male;medical record;morbidity;neurodisability;neurological complication;newborn;nonhuman;outcome assessment;Queensland;serotype;Australia;adolescentarticle;live birth;case report;central nervous system | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.